Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002617614 | SCV002955491 | uncertain significance | not provided | 2023-04-09 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PGK1 protein function. ClinVar contains an entry for this variant (Variation ID: 1922599). This variant has not been reported in the literature in individuals affected with PGK1-related conditions. This variant is present in population databases (rs782807093, gnomAD 0.005%). This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 93 of the PGK1 protein (p.Val93Ala). |
Revvity Omics, |
RCV003130729 | SCV003814904 | uncertain significance | Glycogen storage disease due to phosphoglycerate kinase 1 deficiency | 2023-07-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004738593 | SCV005345552 | uncertain significance | PGK1-related disorder | 2024-04-23 | no assertion criteria provided | clinical testing | The PGK1 c.278T>C variant is predicted to result in the amino acid substitution p.Val93Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0037% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |